The treatment of blood cancer requires deep clinical expertise, extensive subspecialty experience, and an integrated healthcare system. Conditions such as Hodgkin and Non-Hodgkin lymphoma, leukemia, and multiple myeloma demand not only appropriate therapy, but also continuous evaluation by a highly competent medical team. In response to this need, Mandaya Royal Hospital Puri established the Mandaya Blood Cancer Center—an integrated service center that adopts blood cancer treatment protocols aligned with international referral hospitals, including the National University Hospital (NUH) Singapore, through collaboration with NCIS–NUH Singapore.
Contents
Blood Cancer Specialist Team at the Mandaya Blood Cancer Center
Medical Hematology-Oncology consultants (KHOM) are internal medicine subspecialists with specific expertise in diagnosing and treating a wide range of blood disorders, including blood cancer. The Mandaya Blood Cancer Center is supported by five experienced KHOM specialists who are ready to deliver comprehensive, patient-centered care tailored to individual clinical conditions.
1. dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM
dr. Toman is an internal medicine specialist with a subspecialty in Medical Hematology-Oncology, graduating from the Faculty of Medicine, University of Indonesia, and completing his specialist training at Cipto Mangunkusumo Hospital. He further enhanced his expertise through an Honorary Fellowship (Clinical Observership) at the Department of Hematology, National University Hospital (NUH), Singapore.
In clinical practice, dr. Toman has extensive experience managing blood cancer patients using various modern therapeutic approaches, including chemotherapy, immunotherapy, targeted therapy, and apheresis procedures.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. dr. Alvin Tagor Harahap, Sp.PD-KHOM
dr. Alvin Tagor Harahap is an internal medicine specialist with a subspecialty in Medical Hematology-Oncology who completed both his medical degree and specialist training at the Faculty of Medicine, University of Indonesia. He has broad experience in treating blood cancer and hematologic disorders through a comprehensive medical approach.
His services include chemotherapy, immunotherapy, targeted therapy, and apheresis procedures tailored to each patient’s clinical condition.
Practice schedule at Mandaya Royal Hospital Puri:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. Aru W. Sudoyo is widely recognized as one of Indonesia’s leading figures in hematology and oncology. He completed his medical education, internal medicine specialization, and Medical Hematology-Oncology consultancy training at the Faculty of Medicine, University of Indonesia, where he also earned his doctoral degree.
His expertise includes advanced cancer therapies such as chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy. He has also played an active role in the development of national cancer services.
Practice schedule at Mandaya Royal Hospital Puri:
-
Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. Andree Kurniawan is an internal medicine specialist and Medical Hematology-Oncology consultant with extensive experience in managing blood cancer and hematologic disorders. He is proficient in various modern treatment modalities, including chemotherapy, immunotherapy, and targeted therapy.
His clinical approach is highly personalized and focused on each patient’s specific needs to achieve optimal therapeutic outcomes.
Practice schedule at Mandaya Royal Hospital Puri:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K)
dr. Nia Noviantri Siregar is an internal medicine specialist and Medical Hematology-Oncology consultant who focuses on the treatment of blood cancer and complex hematologic disorders. She has extensive experience in chemotherapy, immunotherapy, and targeted therapy, applying a comprehensive approach based on the latest medical advancements.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Integrated Facilities and Services at the Mandaya Blood Cancer Center
To support the expertise of its specialist team, the Mandaya Blood Cancer Center is equipped with modern medical facilities and integrated services that cover all stages of blood cancer care.
1. Hematopoietic Stem Cell Transplant (HSCT)
HSCT is a stem cell transplantation procedure aimed at replacing bone marrow damaged by blood cancer with healthy blood-forming stem cells, allowing normal blood cell production to be restored.
2. ICIR/PICIR (Immunocompromised Room)
Mandaya Royal Hospital Puri provides specialized treatment rooms for patients with weakened immune systems following HSCT. These ICIR/PICIR facilities are designed to minimize the risk of infection during treatment and recovery.
Read also: Stage 4 Blood Cancer: What Treatment Options Are Available?
3. Irradiated Blood Transfusion
Irradiated blood transfusion services are available to prevent serious complications such as Transfusion-Associated Graft-Versus-Host Disease (TA-GvHD), particularly in blood cancer patients after stem cell transplantation.
4. Comprehensive Systemic Therapy
Patients have access to a full range of systemic therapies, including chemotherapy, immunotherapy, targeted therapy, and radiotherapy, tailored to the type and stage of blood cancer.
5. Digital PET/CT Scan
Digital PET/CT Scan technology is used to help physicians precisely evaluate the location, activity, and spread of cancer cells, both during initial diagnosis and in therapy response monitoring.
6. Flow Cytometry
Flow cytometry examinations are conducted as part of advanced laboratory evaluations to analyze the characteristics of blood cancer cells and assess treatment effectiveness.
Read also: 6 Types of Leukemia (Blood Cancer) You Should Know
7. Apheresis Services
Apheresis is used to reduce abnormal blood components, such as excessive white blood cells in leukemia, and to adjust blood components according to patient needs, enabling faster symptom control.
Mandaya–NUH Singapore Collaboration for More Accurate Blood Cancer Care
The Mandaya Blood Cancer Center at Mandaya Royal Hospital Puri has established a strategic collaboration with NCIS–NUH Singapore through cross-border multidisciplinary case discussions. Each patient is jointly evaluated by medical teams from Mandaya and NUH Singapore to ensure accurate diagnosis and the most appropriate therapy selection.
Erwin Suyanto, Public Relations Manager of Mandaya Hospital Group, stated that the establishment of the Mandaya Blood Cancer Center reflects Mandaya Royal Hospital Puri’s commitment to delivering cancer services that are directly connected with leading global cancer referral centers. This collaboration enables more precise treatment recommendations and continuous improvement in the quality of blood cancer care in Indonesia.
With comprehensive facilities and strong international collaboration, Mandaya Royal Hospital Puri continues to strengthen its role as an international-standard blood cancer referral hospital.
To make your visit to Mandaya Royal Hospital Puri more convenient, you can use the Chat via WhatsApp feature, Book Appointment service, or the Care Dokter application, available for download on Google Play and the App Store, to simplify visits, check queue numbers, and access complete information.
